TW200948966A - Oral care methods and systems - Google Patents

Oral care methods and systems Download PDF

Info

Publication number
TW200948966A
TW200948966A TW98103785A TW98103785A TW200948966A TW 200948966 A TW200948966 A TW 200948966A TW 98103785 A TW98103785 A TW 98103785A TW 98103785 A TW98103785 A TW 98103785A TW 200948966 A TW200948966 A TW 200948966A
Authority
TW
Taiwan
Prior art keywords
bacteria
amount
plaque
arginine
oral
Prior art date
Application number
TW98103785A
Other languages
Chinese (zh)
Other versions
TWI424063B (en
Inventor
Richard Scott Robinson
Thumm Laurence Du
ya-nan Hu
Stacey Lavender
Ralph Peter Santarpia Iii
Zhiqiang Liu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of TW200948966A publication Critical patent/TW200948966A/en
Application granted granted Critical
Publication of TWI424063B publication Critical patent/TWI424063B/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

This invention relates to methods of assessing the bioflora of the mouth and of providing appropriate treatment utilizing a basic amino acid in accordance with the assessment.

Description

200948966 六、發明說明: 本申明案主張2008年2月9曰申請之美國專利申請案 序號61/〇27,437案之優先權;亦請求2〇〇8年2月9日申請200948966 VI. INSTRUCTIONS: This application claims the priority of the US Patent Application No. 61/〇27,437 filed on February 9th, 2008. It also requests the application on February 9, 2008.

61/027,431、61/027,420、與 61/027,435 | 等申請案之内容全部併入本文以資參考。 【發明所屬之技術領域】 本發明係有關㈣含有呈_或鹽—性胺基酸之組 成物測量口中致齲齒及分解精胺酸細菌之相對量之方法 (例如,為牙齒保健法之一部分)。 4 【先前技術】 精胺酸及其他驗性胺基酸已被建議用於口腔保健及被 料在對肢料纽牙#誠上具㈣大益處。市售可 » 得之精胺酸系牙膏為含CaviStat⑧之DenClude⑧與The contents of the applications of 61/027, 431, 61/027, 420, and 61/027, 435, are incorporated herein by reference in their entirety. TECHNICAL FIELD OF THE INVENTION The present invention relates to (d) a method for measuring the relative amount of caries and bacteria decomposing arginine in a mouthpiece containing a composition of _ or a salt-based amino acid (for example, as part of a dental care method) . 4 [Prior Art] Arginine and other amidine acids have been suggested for oral health care and are of great benefit to the limbs. Available in the market » The arginine toothpaste is DenClude8 with CaviStat8 and

ProClude® (其中含有精胺酸與碳酸氫碎)。 口中生物菌叢種類通常於形成蛀牙及口腔衛生上扮演 重要角色。舉例而言,一般假設精胺酸有利作用之重要因 素在於其與其他鹼性胺基酸可被特定種_細菌[例如血鏈 20 _(&麵_)]代謝,彼等細菌不會產生触且與致鶴齒 細菌[例如變形鏈球菌(&競爭牙齒上與口腔中之 位置。分解精胺酸之細菌可利用精胺酸及其他鹼性胺基酸 200948966 產生氨:因而提高其環境之pH值;而致麟濟細菌代謝糖 則產生乳酸,傾向於降低牙 除牙齒之礦物ProClude® (which contains arginine and hydrogencarbonate). The type of biological flora in the mouth usually plays an important role in the formation of cavities and oral hygiene. For example, it is generally assumed that an important factor in the beneficial effects of arginine is that it can be metabolized with other basic amino acids by specific species of bacteria [eg blood chain 20 _ (& face)], and these bacteria do not produce Contact with the crane tooth bacteria [eg Streptococcus mutans (& compete with the teeth and the position in the mouth. The bacteria that break down arginine can use ammonia and other basic amino acids 200948966 to produce ammonia: thus improving their environment The pH value; and the lignin metabolism of sugar produces lactic acid, which tends to reduce the minerals of the teeth.

質’最後導舰?。 P 5 10 15 f T有有效方去可監測口巾生物*叢以’例如, 決疋取適療法及監―患治療之有效性,將會很有用。 【發明内容】 法。本發明提供用於評估口中生物菌叢之迅迷又簡單之方 於第-具'體^管1 >( 定分解精胺酸細5中,本發明測定牙菌斑氮產屯量以確 固之相對族鮮。 於另一具體實例φ,士於 致齲齒細菌乏4 τ ’本發明測定牙菌斑乳酸量以確定 吗、相ff族群。 於另〜具徵實例中… (PCR)(例如定量g 本發明使用聚合酶鏈反肩 液中)之生物。時PCR)1^監^口中(例如 ,牙菌斑或$ 於另一' 實例中 以鑑定口中(例如,本發明使用反轉錄酶PCR (RT-PCB 於另 ’牙菌斑或唾液中)之生物菌叢。 、體實例中,後 探針)以鑑h中 ^吏用抗體探針(例如,螢光抗楚 舉例而言,本a〜曰菌斑或唾液中)之生物菌叢。 形鏈球菌)及至少^明疋置至少—種致齲齒細菌(例如,銳 種分解精胺酸細菌(例如,上菌): 20 200948966Quality 'final guide ship? . It is useful to have P 5 10 15 f T to be effective in monitoring the smear biopsy. For example, it is useful to determine the effectiveness of the treatment and the treatment. SUMMARY OF INVENTION The present invention provides a method for assessing the fascination of the biological flora in the mouth and is simple in the first method of the body tube 1 > (Decomposition of arginine fine 5, the present invention determines the plaque nitrogen production amount to confirm In another specific example, φ, the sputum bacteria lacks 4 τ '. The present invention determines the plaque lactic acid amount to determine the ff group, in the other example (PCR) (for example) Quantification g of the present invention using a polymerase chain backwash (in the case of PCR) 1) in the mouth (for example, plaque or in another 'example to identify the mouth (for example, the use of reverse transcriptase in the present invention) PCR (RT-PCB in another 'plaque or saliva) of the biological flora. In the body example, the post-probe) to use the antibody probe (for example, fluorescent anti-Chu, for example, The abundance of the abundance of at least a species of cariogenic bacteria (for example, the genus of serotonin bacteria (for example, bacteria): 20 200948966

於另-具體實例 患,並據此指示治療 中,係使用前述方法之一者評估病 本發明方法 化,而於對牙齒 行續正治療。 特別係用於檢測牙菌斑生態之潛在有害變 有可剩量或顯著脫礦化或傷害之前得以進In another embodiment, and in accordance with the indication of treatment, one of the methods described above is used to assess the method of the invention, and the treatment of the tooth is continued. In particular, it is used to detect the potentially harmful changes in the plaque ecology. There is a residual amount or significant demineralization or damage before entering.

ίο 15 &月因而提供增進口腔健康之方法以,例如 a. 減少或抑制形成齲齒; b. 減少或抑制牙齒之脫礦化作用及促進礦化作用; c. 治療'減少或抑制早期牙轴質病變; d·減少牙齒之過敏反應; e•減少或抑制牙齦炎; f·促進口中潰瘍或傷口之癒合; g. 減少產酸細菌量; h. 增加分解精胺酸細菌之相對量; i. 抑制口腔中微生物生物膜之形成; j. 於糖刺激後提升及/或維持牙菌斑於至少pH 5.5 之程度; k. 減少牙菌斑堆積; l. 治療、緩和或減少口乾; 5 20 200948966 m.美白牙齒; η.增進全身健康,包括心血管健康(例如’利用減少經 由口腔組織之全身性感染之可能性); 〇.使牙齒對致齲齒細菌及其作用免疫; Ρ.清潔牙齒及口腔及/或 q·減少牙齒腐蝕; 該方法包括測量口腔之生物菌叢(例如,使用前述任何方 法)’若必要’則投與含有效量驗性胺基酸(例如’精胺酸) 或其鹽之口腔保健產品。 本發明進一步提供使用呈游離或鹽塑之鹼性胺基酸製 造藥劑’針對根據本發明方法所測量,其口腔生物菌叢含 有致鑛齒細菌量上升及/或乳酸量上升、及/或分解精胺酸細 菌量及/或低牙菌斑氨產生量低之患者,增進口腔健康之用 途。 本發明進一步提供增進口腔美觀之方法(其中該等增 進美觀可包括例如使牙齒更潔白及/或減少口臭),該方法 包括使用根據本發明之方法測量口腔生物菌叢,若指示出 =致齲齒細菌量升高及/或乳酸量升高、及/或出現分解精胺 酸細菌量下降及/或牙菌斑氨產生量下降,則投與含有呈游 離或鹽型驗性胺基酸之口腔保健產品。 200948966 【實施方式】 牙菌斑代謝-氨產生量 精胺酸為氨之能力係分解精胺酸活性之指 5 ❹ 10Ίο 15 & months thus provide methods for improving oral health, such as a. reducing or inhibiting the formation of dental caries; b. reducing or inhibiting demineralization of teeth and promoting mineralization; c. treatment 'reducing or inhibiting early dental shafts D. Reduce allergic reactions to teeth; e• Reduce or inhibit gingivitis; f· Promote healing of ulcers or wounds in the mouth; g. Reduce the amount of acid-producing bacteria; h. Increase the relative amount of bacteria that break down arginine; To inhibit the formation of microbial biofilms in the oral cavity; j. to promote and/or maintain plaque at a pH of at least 5.5 after sugar stimulation; k. reduce plaque build-up; l. treat, alleviate or reduce dry mouth; 20 200948966 m. Whitening teeth; η. Enhancing general health, including cardiovascular health (eg 'utilizing the possibility of reducing systemic infections through the oral tissues'); 〇 making the teeth immune to caries bacteria and their effects; Tooth and mouth and/or q. reduce tooth erosion; the method comprises measuring the bacterial flora of the mouth (eg, using any of the methods described above), if necessary, administering an effective amount of an amino acid (eg, Arginine) or salt thereof in oral care products. The invention further provides for the manufacture of a medicament using a basic amino acid which is free or salt-formed, as measured by the method according to the invention, wherein the oral biota contains an increase in the amount of ore-producing bacteria and/or an increase in the amount of lactic acid, and/or decomposition Patients with low levels of arginine bacteria and/or low plaque ammonia production improve oral health. The invention further provides a method of enhancing the aesthetics of the mouth (wherein enhancing aesthetics may include, for example, making the teeth whiter and/or reducing bad breath), the method comprising measuring the oral flora using the method according to the invention, if indicated = causing the tooth If the amount of bacteria is increased and/or the amount of lactic acid is increased, and/or the amount of bacteria decomposing arginine is decreased and/or the amount of plaque ammonia is decreased, the oral cavity containing the free or salt-type amino acid is administered. Health Care Products. 200948966 [Embodiment] Plaque metabolism-ammonia production The ability of arginine to ammonia is a factor for decomposing arginine activity 5 ❹ 10

;會:二Γ化精胺酸為氨之能力,正如同某些細 囷會轉化糖類為^。增加分解精賴8株之 細菌產生對致_細菌增殖(此增殖:愛酸 =件增ΐ牙風險)不利之條件。每天使用精胺酸被預 /月可以類似、經吊攝食糖產生有利於產酸細菌的條件之方式 而產生有利料解精月安酸細菌之牙菌斑 中和酸之驗,有助於維持中性牙菌斑ΡΗ。中性 非病=細隨為有利。賴於測定所挑選之分解精胺酸細 菌之濃度而未區分具代謝活性(活)與失活(死)細菌之即時 PCR法(於下文進一步敘述),測量氨產生量可測定能轉化 精胺酸為氨的所有細菌之貢獻。 氨檢測套組為市售可得,例如,得自Diagn〇stic Chemicals Limited (Oxford,CT),可測定氨產生量,其定量 及測定之原理為已知氨與α-酮戊二酸及還原型菸鹼醯胺腺 嘌呤二核苷酸磷酸(NADPH)反應形成L-麩胺酸及NADp ; 此反應由麵胺酸脫氫酶(GLDH)催化;由於NADPH氧化而 於340 nm之吸光率降低係與氨濃度成正比。經預定治療流 程後’收集牙菌斑試樣。於若干應用中,牙菌斑係自裝於 固定器(retainer)上之釉質或HAP樣品獲得。於其他應用 中,牙菌斑直接自牙齒獲取。 20 200948966 根據乳酸量之牙菌斑生態 正如同測量氨量作為衡量分解精胺酸細菌量之代理物 (proxy) ’乳酸係衡量致齲齒細菌量之代理物。進行牙菌致 取樣之患者從前一天晚上即不再進食或喝水,早上也不 5 10 15 牙;以10%蔗糖溶液沖洗2分鐘;8分鐘後,刮除牙齒^ 面,收集牙菌斑。將牙菌斑試樣收集於置於冰上之預先^ 重之官中,並測量牙菌斑重。其分析包括添加冰冷的水於 0 已知量牙菌斑試樣中,接著加熱試樣至8〇〇C5分鐘以殺死 細菌及釋出所有酸,然後將試樣置於冰水中冷卻5分鐘。 接著離心試樣,過濾上澄液。使用毛細管電泳法測定乳酸 浪度。 根據定量即時PCR之牙菌斑生態 定量即時PCR (聚合酶鏈反應)係定量DNa之高度靈 ^方法。由於DNA量與存在之細菌量直接相關,因此使用 單離自牙菌斑之細菌DNA定量總細菌量。即時pcR被例 如美國疾病防治中心(Center for Disease Control)與FDA等 政府機構公認為強有力且靈敏之技術。利用許多口腔細菌 之已知基因體序列,設計探針以檢測口腔細菌或特定細菌 例=變形鏈球菌或血鏈球菌之總量。利用聚合酶鏈反應擴 增單離自牙菌斑或唾液試樣之DNA。DNA量隨各pCR反 應循環呈指數遞增。由於反應係經使用螢光報導分子後即 時進行,因此該技術被稱為“即時,,。於本發明之一具體實 例中,係使用SYBR Green作為報導分子。此分子^雙股 20 200948966; will: the ability of diterpene arginine to ammonia, just as some fine sputum will transform sugar into ^. Increasing the bacteria that decomposes the 8 strains produces conditions that are unfavorable for the proliferation of _ bacteria (this proliferation: love acid = increase the risk of tooth decay). The use of arginine per day can be similar to that of sucrose-producing bacteria in the form of conditions that favor the production of acid-producing bacteria. Neutral plaque. Neutral Non-disease = fine as a benefit. Depending on the concentration of the selected arginine-degrading bacteria selected without the distinction between metabolically active (live) and inactivated (dead) bacteria (as described further below), the amount of ammonia produced can be measured to determine the conversion of spermine The contribution of all bacteria to which the acid is ammonia. Ammonia test kits are commercially available, for example, from Diagn〇stic Chemicals Limited (Oxford, CT), which can measure the amount of ammonia produced. The principle of quantification and determination is known as ammonia and alpha-ketoglutaric acid and reduction. Type nicotine indoleamine adenine dinucleotide phosphate (NADPH) reacts to form L-glutamic acid and NADp; this reaction is catalyzed by alanine dehydrogenase (GLDH); the absorbance at 340 nm is reduced due to NADPH oxidation It is proportional to the ammonia concentration. The plaque samples were collected after a predetermined treatment procedure. In several applications, plaque is obtained from enamel or HAP samples mounted on a retainer. In other applications, plaque is obtained directly from the teeth. 20 200948966 The plaque ecology based on the amount of lactic acid Just as the proxy for measuring the amount of arginine bacteria as a proxy for measuring the amount of ammonia, the lactic acid system is a proxy for the amount of caries caused by caries. Patients who were sampled by plaque stopped eating or drinking water the night before, and did not take 5 10 15 teeth in the morning; rinsed with 10% sucrose solution for 2 minutes; after 8 minutes, scraped the teeth and collected plaque. The plaque samples were collected in pre-weighted organs placed on ice and the plaque weight was measured. The analysis consisted of adding ice-cold water to a known plaque sample of 0, then heating the sample to 8 ° C for 5 minutes to kill the bacteria and release all the acid, then cooling the sample in ice water for 5 minutes. . The sample was then centrifuged and the supernatant was filtered. The lactic acid wave length was measured by capillary electrophoresis. Quantitative real-time PCR (polymerase chain reaction) based on quantitative real-time PCR is a method for quantifying DNa. Since the amount of DNA is directly related to the amount of bacteria present, the total bacterial amount is quantified using bacterial DNA isolated from dental plaque. Instant pcR is recognized as a powerful and sensitive technology by government agencies such as the Center for Disease Control and the FDA. Probes are designed to detect oral bacteria or specific bacteria, such as the total amount of Streptococcus mutans or Streptococcus sanguis, using known gene sequences of many oral bacteria. The DNA isolated from the dental plaque or saliva sample is amplified by polymerase chain reaction. The amount of DNA increases exponentially with each pCR reaction cycle. Since the reaction is carried out immediately after the use of fluorescent reporter molecules, the technique is referred to as "instant," and in one specific embodiment of the invention, SYBR Green is used as a reporter molecule. This molecule is a double strand 20 200948966

❹ ίο 15 DNA配合後強烈發螢光。利用設定螢光臨界值(thresh〇ld) 及使用各種濃度之DNA標準確定達到該臨界值需要之循 環數而達成定量。存在的DNA愈多,達到臨界值需要之 DNA循環數愈少。市售之即時PCR儀器可自許多廠商(例 如 Roche Diagnostics)購得。 牙菌斑試樣係自具已知及固定表面積之牙釉質或經基 磷灰石樣本獲得。牙菌斑收集之標準化相當具關鍵性,因 為DNA存在量與收集之牙菌斑量直接關聯。使用牙菌斑量 作為即時PCR測定的總細菌量標準化之方法並不適當,因 為此一1顯著相關。結果記錄為每毫升之微克DNA。可就 DNA濃度或Ln(DNA濃度)進行統計分析。關於總細菌量 (total bacteria)係使用患者及治療為因子進行二因子變異數 分析(ANOVA)。若差異性檢測出95%信賴標準,則彼等 異,被視為顯著。就特定細菌例如變形鏈球菌或▲鍵球 而言,係使用總細菌量作為互變量進行二因子變異數八 析:菌總量由於與細菌族群總量有關,因此為牙; 斑生態健康更恰當之指標。 勺孑囷 於本發明之特定具體實例中,測 致齲齒性之指標;選用變形鏈球菌乃 作為 關之公認危險因子。雖有1 ,、為/、口動蛀牙有 口于雖有其他產酸細菌涉及蛀牙巩扫w 一般已知變形鏈純+ 汉班才過程,惟 角色。於齲過程開始及早期扮演重要 角色於本發明—具體實例中 、董要 更健康牙g斑生態之餘鏈球19作為轉移至 玍〜、之扣‘,因—般已知血 9 20 200948966 解精胺酸雜(轉化精紐為氨之能力)之細菌。 根據RT-PCR之牙菌斑生態 反轉錄PCR測定試樣中之RNA轉錄本。單離出RNA, 使用反轉錄酶將轉錄本轉化為cDNA,並使用pcR擴増 5 fNA R11PC:R <優點為DNA系之σ腔細ϋ檢測法無法 檢測彼等菌種之存活性。因為口腔細菌最常於生物膜群落 中被發現,死細菌之DNA可於死後長時期保留 = 構中。其他方法,例如榮光系存活性測定法(UveDeadi; Molecular Probes),可檢測生物體是否具有受損害之膜 10 (C〇mpr〇mised membranes),惟不能直接檢測特定菌種。、 因此反轉錄即時PCR方法為定量存在複雜群落中 定口腔細g g株活生物體之方法。mRNA具相當短之声 期,因此為新近活細菌之指標。申請人等已開^出對延^ 因子加/(elongatum factor加力具菌種特異性之引子。 15 目不X生長階段、培養基或環境條件明顯調控,因而將二 檢測細菌數之虛擬影響減至最小。使用放線共生放線3 你r⑽/卿少她嶋所"娜)作為干 體,於少至/〇%活生物體存在時,亦可於活細菌與被^ 殺死的細囷之混合族群中檢測出存活差異性 20 祕以於含有多達六種不同㈣_之混相^群=; 靠地鑑定放線共生放線桿菌之存在。所計算之细' :y 根據相同培養物之〇D6I。估計之數值密切相M〇;= 農度與 異性<1%)。此測定法代表於口腔複雜環境中研究特定生= 200948966 體生態之方法。认士 可開發出1 有步之基因序列資料可利用時,即 x見廣種類口腔細菌之引子。 根據螢光抗體探針之細菌量 5❹ ίο 15 Intensely fluorescing after DNA is combined. Quantification is achieved by setting the fluorescence threshold (thresh〇ld) and using the DNA standards of various concentrations to determine the number of cycles required to reach this threshold. The more DNA that is present, the less the number of DNA cycles required to reach a critical value. Commercially available real-time PCR instruments are commercially available from a number of manufacturers, such as Roche Diagnostics. Plaque samples were obtained from enamel or base-based apatite samples of known and fixed surface area. The standardization of plaque collection is critical because the amount of DNA present is directly related to the amount of plaque collected. The use of plaque amount As a method of standardizing the total bacterial amount measured by real-time PCR, it is not appropriate, and as a result, it is significantly correlated. The results were recorded as micrograms of DNA per milliliter. Statistical analysis can be performed on DNA concentration or Ln (DNA concentration). The total bacterial count was analyzed by a two-factor variance analysis (ANOVA) using the patient and the treatment as a factor. If the difference detects a 95% confidence criterion, then they are considered to be significant. For a specific bacterium such as Streptococcus mutans or ▲ bond ball, the total bacterial amount is used as a cross-variable to analyze the two-factor variation: the total amount of bacteria is related to the total bacterial population, so it is a tooth; Indicators. Spoon 于 In the specific embodiment of the present invention, the index of caries is measured; Streptococcus mutans is selected as a recognized risk factor. Although there is 1, , /, mouth and mouth, there are mouths, although there are other acid-producing bacteria involved in the sputum tooth sweep, generally known as the deformation chain pure + Hanban process, but the role. At the beginning and early stage of the process, the author played an important role in the present invention. In the specific example, Dong wants a healthier tooth g-ecosphere, and the chain 19 is transferred to the 玍~, the buckle', because the blood is known as 9 20 200948966 Amino acid (the ability to convert sperm into ammonia). RNA transcripts in samples were determined by plaque ecological reverse transcription PCR by RT-PCR. RNA is isolated, reverse transcriptase is used to convert transcripts into cDNA, and pcR is used to expand 5 fNA R11PC: R < Advantages are that the DNA system σ cavity fine sputum detection method cannot detect the viability of these strains. Because oral bacteria are most commonly found in biofilm communities, the DNA of dead bacteria can remain in the structure for a long time after death. Other methods, such as the glory viability assay (UveDeadi; Molecular Probes), can detect whether a organism has a damaged membrane 10 (C〇mpr〇mised membranes), but cannot directly detect a particular species. Therefore, the reverse transcription real-time PCR method is a method for quantifying the presence of a living organism in a complex colony of a fine g g strain. mRNA has a fairly short sound period and is therefore an indicator of newly viable bacteria. Applicants have issued a primer for the specificity of the elongatum factor. The 15th phase does not significantly control the growth stage, medium or environmental conditions, thus reducing the virtual impact of the number of bacteria detected. To the minimum. Use the symbiosis to release the line 3 You r (10) / Qing less her & & 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜 娜Survival differences were detected in the mixed population. 20 The secret phase containing up to six different (four) _ groups =; the identification of the presence of actinomycetes. The calculated fine ':y is based on the same culture as D6I. The estimated values are closely related to M〇; = agronomy and heterosexuality <1%). This assay represents a method for studying specific organisms in the complex environment of the oral cavity = 200948966. Cencus can develop a step-by-step gene sequence data available, that is, x see a wide variety of oral bacteria primers. The amount of bacteria according to the fluorescent antibody probe 5

10 使用虫主牙4斷套組,經由使用單株抗體以檢測唾液中 之致鑛齒型細菌㈣口,變形鏈球菌)及/或非致躺齒裂細菌 (例如,血鏈球菌)之量。所用特定抗體對細菌菌種具特異 性及具有附加於抗體之螢光。細菌量可利用測量發射之螢 光量予以檢測。 實例 實例110 Use the worm main tooth 4 break kit to detect the amount of ore-producing bacteria (4), Streptococcus mutans, and/or non-lying cleavage bacteria (eg, Streptococcus sanguis) in saliva by using monoclonal antibodies. . The specific antibody used is specific to the bacterial species and has fluorescence attached to the antibody. The amount of bacteria can be detected by measuring the amount of fluorescence emitted. Example 1

測量牙菌斑細菌總量之即時PCR 患者之牙菌斑細菌總量(微克細菌DNA/毫升)係使用 各種牙膏調配劑,以前文所述程序進行測量: 250 ppm氟化 物調配劑(對 照組) 總細菌DNA 6.091 變形鏈球菌 DNA 0.09622 血鏈球菌 DNA 1.126 1450 ppm 氟化 物調配劑 6.018 0.099〇3 1.107 具有2%精胺 酸碳酸氫鹽與 1450 ppm 氟化 物之調配劑 3.781 0.05998 1.291 ⑩ 11 200948966 精胺酸-氟化物調配劑有效地減少總細菌牙菌斑荷載 量與變形鏈球菌(致鱗齒)牙菌斑荷載量,而增加血鏈球菌 (分解精胺酸)荷載量。 實例2-氨產生量 5 氨產生量係使用各種牙膏調配劑,以上文所述程序進 行測量: 氨量(ppm) 250 ppm貌化物調配 1·97 劑(對照組) 1450 ppm氟化物調 1.79 配劑 具有2%精胺酸碳酸 2.77 氫鹽與1450 ppm氟 化物之調配劑 使用含精胺酸調配劑患者牙菌斑中之氨產生量明顯較 高。 實例3 -乳酸量 10 患者牙菌斑乳酸量係如上文所述使用毛細管電泳法進 行測量,結果顯示於蔗糖存在下,乳酸顯著增加。 牙囷斑 蔗糖刺激之牙 菌斑 乳酸 (奈莫耳/毫克) 1.87 7.82 ± 0.37 12 200948966The total amount of plaque bacteria (microgram bacterial DNA/ml) in real-time PCR patients measuring total plaque bacteria was measured using various toothpaste formulations, as described previously: 250 ppm fluoride formulation (control) Total bacterial DNA 6.091 Streptococcus mutans DNA 0.09622 Streptococcus sanguis DNA 1.126 1450 ppm Fluoride formulation 6.018 0.099〇3 1.107 Formulation with 2% arginine bicarbonate and 1450 ppm fluoride 3.78 0.05998 1.291 10 11 200948966 Spermine The acid-fluoride blending agent effectively reduces the total bacterial plaque load and the plaque load of Streptococcus mutans (striate) and increases the load of Streptococcus sanguis (decomposed arginine). Example 2 - Ammonia Production Amount of ammonia produced using various toothpaste formulations, measured as described above: Ammonia (ppm) 250 ppm Topical Formulation 1.97 (Control) 1450 ppm Fluoride 1.79 The formulation has 2% arginine carbonate 2.77 hydrogen salt and 1450 ppm fluoride. The ammonia production in the plaque of patients with arginine formula is significantly higher. Example 3 - Amount of lactic acid 10 The plaque lactic acid amount of the patient was measured by capillary electrophoresis as described above, and the results showed that lactic acid was significantly increased in the presence of sucrose. Plaque sucrose-stimulated teeth plaque lactic acid (namol/mg) 1.87 7.82 ± 0.37 12 200948966

貝例4 ·即時PCR / RT-PCR 性指合制信使腿㈣取)作為細胞内生物活 化菌種即時PCR檢測之原理。自細菌試樣純 雜環境中i ^用反轉錄即時P C R檢測錢量單純或複 瓜腿幾定方法及其應用。盎料子之序列以及Shell Example 4 · Real-time PCR / RT-PCR refers to the principle of instant PCR detection of intracellular bioactive bacteria. From the pure environment of the bacterial sample, i ^ uses the reverse transcription instant P C R to detect the amount of simple or complex legs and its application. The sequence of ounces and

ίο 15 ❿ 編碼心ί中舰之一功能為編碼以合成蛋白質。DNA 南與H之"歷股’接著被作為喊最終蛋白質之指 鐘),且。户不同’抓财具有很短之半衰期(數秒至數分 在細胞中、=活或剛細胞中;DNA以固定套數存 不同蛋㈣❿歷I則常反應細胞存活之條件而變化。 質之表現可能反應溫度變化、生長培養基、生長 皆段與其他環境條件而向上或向下調節。因此養;未2 ’則環境條件之變動很可能被錯誤解讀為係 ^ 之變動。為了避級等效應,本發明使用延伸 u /基因#’作為標乾序列。因為在不同實驗條件 現甚少變化或無變化,因此此序列先前已被作為 私兄使用。 即時PCR使肢持遺傳物質聚合酶鏈反應(pCR)擴增 用之基礎化學’並連接螢光標記之即時檢測(其為定量各 =循環後存在之既絲因序列套數之機制) 。彼等方法之 取間易者為使用SYBR Green !〜種特異性地嵌入雙股 DNA (dsDNA)中之螢光探針;因此SYBR 榮光增加 13 20 200948966 量與較高dsDNA濃度相關。當此染料併入主要使用特定基 因序列之PCR反應中時,則螢光之增加相當於標靶基因套 數之增加。隨後,訊號越過預定強度臨界值之循環數與起 始物質中基因序列之濃度相關。 即時P C R技術之開發已使其可迅速且高精確度地檢測 及疋量特定生物物種。用於定量細菌菌種之習知方法依賴 針對編碼16s核糖體次单元DNA可變區之引子之開發。此 -人單元對細菌複製具關鍵性’因此,其序列不易突變。董子 特疋菌種具特異性之16s rDNA序列之檢測有助於複雜環 境中單一細菌菌種之檢測與計數。 引子之設計係根據得自公開可用資料庫(Nati〇nal Center for Biotechnology Information and the Los Alamos Oral Pathogens Database)之諸如/基因之序列。使用DNA Star Lasergene程式MegAlign標準元件排列諸序列。此排 列係用於挑選具較大分岐性之區域,俾使菌種特異性之相 似度增至最大。引子序列之挑選係根據得自R〇che Diagnostics LightCycler Probe Design 軟體之資訊分析。本 發明所涵蓋之引子不僅包括已經設計及測試者,亦包括針 對口腔病原菌此基因部位之所有引子。 使用適當RNA單離套組或其他rna單離方法自試樣 中單離全部RNA ;可使用單離rnA之任何較佳方法。經 純化之RNA以適當DNase處理試劑處理2次;此步驟降 解RNA製備物内任何污染之DNA,及防止獲得偽陽性結 200948966 果。然後反轉錄單離之RNA ’以產生互補dna (cDNA)分 子’擴增所得cDNA ’使用SYBR Green進行檢測。可進行 無反轉錄步驟之即時PCR反應,以作為完全去除dna之 品質管控;缺乏反轉錄反應獲得之PCR產物必為污染dna 5 之結果。 針對自含已知量活細菌之培養物單離之RNA試樣進 行即時反轉錄PCR反應,以產生標準曲線。以各已知試樣 ❹ 之二階導數(second derivative)最大值對其細菌細胞之已知 濃度作圖。接著可將自未知細菌試樣單離的RNA擴增曲線 之一卩自v數最大值與s亥標準曲線進行比較,以確定試樣族 群中活生物體之濃度。此數據於遏制抗細菌劑與活性分子 對口腔環境生態之影響時將為有價之資訊。 下述引子對係設計用以擴增得自放線共生放線桿菌 加/基因之一 228個鹼基對區域:Ίο 15 ❿ One of the codes in the heart of the ship is encoded to synthesize proteins. The DNA South and H" calendar stocks are then used as a reminder of the final protein). Different households have a very short half-life (several seconds to several points in the cell, = live or fresh cells; DNA with a fixed number of different eggs (four) ❿ calendar I often reflect the conditions of cell survival. Qualitative performance may Changes in reaction temperature, growth medium, growth, and other environmental conditions are adjusted upwards or downwards. Therefore, changes in environmental conditions are likely to be misinterpreted as changes in the system. The invention uses extended u / gene #' as the stem sequence. Since there are few or no changes in different experimental conditions, this sequence has previously been used as a private brother. Instant PCR enables limbic genetic material polymerase chain reaction (pCR) ) The basic chemistry for amplification 'and the simultaneous detection of fluorescent markers (which is the mechanism for quantifying the number of sets of silk due to the number of strands after the cycle). The method of using these methods is to use SYBR Green! Fluorescent probes specifically embedded in double-stranded DNA (dsDNA); therefore, the amount of SYBR glory increased by 13 20 200948966 is related to higher dsDNA concentrations. When this dye is incorporated, the specific gene sequence is used. In the PCR reaction, the increase in fluorescence corresponds to an increase in the number of sets of target genes. Subsequently, the number of cycles in which the signal crosses the predetermined intensity threshold is related to the concentration of the gene sequence in the starting material. The development of real-time PCR technology has made it possible Rapid and highly accurate detection and measurement of specific biological species. The conventional methods for quantifying bacterial species rely on the development of primers encoding the variable region of the 16s ribosomal subunit DNA. This human unit is critical for bacterial replication. Sexuality, therefore, its sequence is not easily mutated. The detection of the 16s rDNA sequence specific to the species of the genus Diptera is helpful for the detection and enumeration of single bacterial species in complex environments. The design of the primer is based on a publicly available database. (Nati〇nal Center for Biotechnology Information and the Los Alamos Oral Pathogens Database) sequences such as/genes. Sequences are arranged using the DNA Star Lasergene program MegAlign standard elements. This arrangement is used to select regions with greater tillering properties, The similarity of strain specificity is maximized. The selection of primer sequences is based on the selection of R〇che Diagnostics LightCycl. Information analysis of er Probe Design software. The primers covered by this invention include not only those who have been designed and tested, but also all primers for this gene part of oral pathogens. Use appropriate RNA detachment kit or other rna detachment method from sample Any single RNA can be isolated; any preferred method of isolation from rnA can be used. The purified RNA is treated twice with the appropriate DNase treatment reagent; this step degrades any contaminating DNA in the RNA preparation and prevents false positive junctions from being obtained. . The transcribed RNA' was then reverse transcribed to produce a complementary dna (cDNA) molecule' amplified cDNA' was detected using SYBR Green. An immediate PCR reaction without a reverse transcription step can be performed as a quality control for complete removal of DNA; PCR products obtained without a reverse transcription reaction must be the result of contamination of DNA 5. An immediate reverse transcription PCR reaction was performed on RNA samples isolated from cultures containing known amounts of live bacteria to generate a standard curve. The known concentration of the second derivative of each known sample 作 is plotted against its known concentration of bacterial cells. One of the RNA amplification curves isolated from the unknown bacterial sample can then be compared from the maximum value of the v number to the standard curve of the shai to determine the concentration of living organisms in the sample population. This data will be valuable information to curb the effects of antibacterial and active molecules on the environmental ecology of the oral cavity. The following primer pairs were designed to amplify a 228 base pair region derived from the actinomycete A. faecalis plus/gene:

Tm %GC AG 黏合 (C) (千卡/溫度 莫耳) 49.05 56.25 -27.56 55°C φ 引子序列 名稱 前置5’一 AAGCGCGTGGTATCAC 3,Tm %GC AG Bonding (C) (kcal/temperature Moh) 49.05 56.25 -27.56 55°C φ Initiator Sequence Name Front 5' A AAGCGCGTGGTATCAC 3,

31.52 40.00 -20.15 55°C 反置5’一 TGTAAGGAACACCTA -3, I5表1·設計用以定量放線共生放線桿_如尺恤做魏之 之性質。 15 200948966 彼等引子係用於擴增自放線共生放線桿菌之純培養物 及包含或不含放線共生放線桿菌之混合族群二者單離之 RNA ;其結果,特別是螢光(F1)與循環數間之關係,示於 圖1。於圖1中,“water”代表純放線共生放線桿菌培養物 之負對照組及“Aa”為其正對照組;“Mix 1”係自含中^普雷 沃 n (PrevoheUa intermedia)、遠緣璉球菌(Strept〇c〇ccus 、口腔鏈球菌(及⑷、與黏放線菌 之族群純化,因此使用彼等引子之擴 增應為陰性;“Mix 3”係得自含放線共生放線桿菌、牙齦卟 琳單胞菌麵g/邮να/的、格氏鏈球菌 (&Γ印幻⑽變形鏈球菌、與血鏈球菌之族群, 放線共生放線桿菌之擴增應為陽性。 此圖表證明,在含放線共生放線桿菌之混合族群以與 正對照組類似之曲線進行擴增之同時,缺乏放線共生放線 桿菌之混合族群則遵循與水對照組相同之擴增曲線;表示 彼等引子能自各種RNA混合物中精確地檢測出放線共生 放線桿菌。 ^ 彼·#引子僅精確地檢測及定量活放線共生放線桿菌生 物體之能力可如下文所述確定。使已知濃度之放線共生放 線桿菌細胞懸浮於8〇%乙醇15分鐘進行殺菌。然後離心使 、,田讀/儿;知儿殺物再懸浮於新鮮Brain Heart Infusion液體 生長培養基中。於370C培養此經乙醇殺死之細菌隔夜,檢 查其生長以證實無活生物體存留。然後使經乙醇殺死之細 200948966 5 ❹ 10 菌以既^比率與活生物體混合,進行反轉錄A隨後之即時 PCR。彼等試樣之擴增示於圖2,自活及死放線 共生放線桿菌混合族群之RN A < ^ # V、 儘管料此反應模㈣之財族群含有彳目_量之生 物體,惟於含較多活生物體之試樣 表示此測定法能於活及死細g混雜較早之擴增, 體。此外’彼等試樣之溶融曲線,^ 3 =剛出活生物 試樣中有單-、相同產物被擴增,證明C所有 ,。圖3顯示自純放線共生放線桿菌及現合特 之產物之㈣峰分析。彼㈣線重疊表 。養物擴增 -產物被擴增。表2顯示於選定標準 ;=單 測值與計算值之比較^ 〜像中生物數預 ❾ 較 試槔 CFU 計算之活_料 CFU 100% 5.00 X 107 5.34 X 1〇7 50% 2.50 X 107 2.28 X 1〇7 40% 2.00 X 1〇7 2.54 X 1〇7 30% 1.50x 107 1.18 X 1〇7 20% 1.00 X 107 1.07 X 1〇7 10% 5.00 X 106 4.06 X 1〇6 5% 2.50 X 106 2.96 X 1〇6 於選定標準曲線試樣中 生物數預測值與 根據活及被殺死之起姶培養物之已知濃声,▲〜 群中活生物體之大略數量,與各擴與曲 a ’計算各族 17擴曰曲線之二階導數最大 15 200948966 值結合使用,以產生標準曲線;其結果如圖4所示,其說 明自已知濃度活及死放線共生放線桿菌之擴增產生之標準 曲線及該標準曲線之線性迴歸;迴歸線之r2值為0.96。 5 10 15 線性迴歸線之r2值表示迴歸等式配合觀測值之接近 性。r2接近1.00表示觀測值與迴歸線密切符合。關於上述 實例,標準曲線之r2值為0.96,表示此線中觀測之約96% 總變異係由於試樣中實際測量之變異,因而此標準曲線可 用於計算未知族群中活生物體之濃度。 實際上,於單一實驗中,根據此標準曲線計算出之活 生物之濃度與進行RNA單離前所添加之實際濃度並無顯 著差異,此差異<20%。彼等數據表示,此測定法代表於複 雜生物族群中檢測及定量特定菌株活生物體之迅速、精確 之方法;係用於分析諸項處理對口腔微生物生態的效應之 潛在有力工具。 【圖式簡單說明】 圖1得自純培養物及混合菌種族群之放線共生放線桿 菌之擴增。 圖2得自活及死放線共生放線桿菌混合族群之RNA之 擴增。 圖3自純放線共生放線桿菌及其混合培養物擴增之產 物之熔融峰分析。 圖4自已知濃度活及死放線共生放線桿菌之擴增產生 之標準曲線及該標準曲線之線性迴歸。 18 2031.52 40.00 -20.15 55 °C Reverse 5' TGTAAGGAACACCTA -3, I5 Table 1 · Designed to quantify the nature of the symbiosis release _ _ such as the ruler to make Wei. 15 200948966 These primers are used to amplify RNA from both pure cultures of Actinobacillus compositae and mixed populations with or without A. faecalis; the results, especially fluorescence (F1) and circulation The relationship between the numbers is shown in Figure 1. In Fig. 1, "water" represents the negative control group of purely symbiotic A. faecalis culture and "Aa" is its positive control group; "Mix 1" is self-contained by Prevohe Ua intermedia, distant Strept〇c〇ccus, Streptococcus faecalis (and (4), and actinomycetes are purified, so amplification using their primers should be negative; "Mix 3" is derived from Actinobacillus actinomycetes, gingiva Streptococcus mutans g/mail να/, Streptococcus mutans (& Γ印幻(10) Streptococcus mutans, and the group of Streptococcus sanguis, the amplification of Actinobacillus actinomycetes should be positive. This chart proves that At the same time that the mixed population containing Actinobacillus actinomycetes was amplified in a similar curve to the positive control group, the mixed population lacking Actinomyces faecalis followed the same amplification curve as the water control group; Accurate detection of Actinobacillus elegans in the RNA mixture. ^ The ability of the _# primer to accurately detect and quantify the live symbiotic A. faecalis organisms can be determined as described below. The bacillus cells were suspended in 8〇% ethanol for 15 minutes for sterilization, then centrifuged, and the rice was read/child; the sera was resuspended in fresh Brain Heart Infusion liquid growth medium. The ethanol-killed bacteria were cultured at 370C. Overnight, check the growth to confirm the retention of inactive organisms. Then, the ethanol-killed fine 200948966 5 ❹ 10 bacteria were mixed with living organisms at the same ratio, and reverse transcription A was followed by real-time PCR. The amplification is shown in Figure 2, RN A < ^ # V of the mixed population of the live and dead line symbiotic Actinobacillus, although the genus of the reaction model (4) contains the organisms of the genus _ _, but contains more living organisms The sample of the body indicates that the assay can amplify the living and dead fine g-mixing earlier, and the melting curve of the samples is further, ^ 3 = single- and identical products in the living biological sample. It was amplified and proved to be C. Figure 3 shows the peak analysis of the products from the purely symbiotic A. actinomycetes and the current products. The (four) line overlap table. The nutrient amplification-products were amplified. Table 2 shows the selection. Standard; = comparison of single measured value and calculated value ^ ~ in the image Bionumber predictions CFU calculated by CFU 100% 5.00 X 107 5.34 X 1〇7 50% 2.50 X 107 2.28 X 1〇7 40% 2.00 X 1〇7 2.54 X 1〇7 30% 1.50x 107 1.18 X 1〇7 20% 1.00 X 107 1.07 X 1〇7 10% 5.00 X 106 4.06 X 1〇6 5% 2.50 X 106 2.96 X 1〇6 Predicted value of biological number in the selected standard curve sample And the known thick sound of the cockroach culture that was killed, ▲~ the approximate number of living organisms in the group, combined with the expansion of the curve a 'calculation of the second derivative of each family 17 expansion curve maximum 15 200948966 value, The standard curve was generated; the results are shown in Figure 4, which illustrates the standard curve generated from the amplification of the known concentration live and dead line A. faecalis and the linear regression of the standard curve; the r2 value of the regression line is 0.96. 5 10 15 The r2 value of the linear regression line indicates the proximity of the regression equation to the observed value. A r2 close to 1.00 indicates that the observed value closely matches the regression line. With respect to the above example, the r2 value of the standard curve is 0.96, indicating that approximately 96% of the total variation observed in this line is due to the actual measured variation in the sample, so this standard curve can be used to calculate the concentration of living organisms in the unknown population. In fact, in a single experiment, the concentration of living organisms calculated from this standard curve was not significantly different from the actual concentration added prior to RNA detachment, and this difference was <20%. According to their data, this assay represents a rapid and accurate method for detecting and quantifying living organisms in specific strains in complex biota; a potential tool for analyzing the effects of various treatments on oral microbial ecology. [Simple description of the diagram] Figure 1 is obtained from the amplification of the symbiotic symbiotic bacillus of the pure culture and the mixed genus. Figure 2 shows the amplification of RNA from a mixed population of live and dead line symbiosis A. faecalis. Figure 3 is a graph showing the melting peaks of products amplified from pure line A. faecalis and its mixed cultures. Figure 4 is a standard curve generated from amplification of a known concentration of live and dead line A. faecalis and a linear regression of the standard curve. 18 20

Claims (1)

200948966 七、申請專利範圍: 1· 一種評估口腔生物菌叢之方法,該 細菌之量。 Λ方法包括测量分解精胺酸 2. 如申請專利範圍第丨項之方法,其 Τ亦測置致齲齒細菌活性。 3. 如申請專利範圍第丨或2項之方法, 活性係利用測量牙菌斑氨產生量進行分解精胺酸細菌 ❹ ίο 鲁 15200948966 VII. Scope of application for patents: 1. A method for assessing oral flora, the amount of bacteria. The sputum method includes measuring the decomposition of arginine. 2. The method of the ninth aspect of the patent application is also used to measure the bacterial activity of the caries. 3. If the method of claim No. 2 or 2 is applied, the active system is used to decompose arginine bacteria by measuring the amount of plaque ammonia produced. ί ίο 鲁 15 4. 如申請專利範圍第2或3之方 係利用測量乳酸產生量進行評估。八中該關齒細菌活性 5· 料利範圍之任—狀枝,財法包括使用定量 =日守取、定量RT_PCR、及/或$光抗體探針以定量至少一 種致齲齒細菌及/或至少一種分解精胺酸細菌之量。 前述申請專韻圍之任—項之方法,其中該分解精胺酸 、、,田圏包括血鏈球菌〇S.卿公此)。 7. f據前述申請專利範圍之任—項之方法,其中亦測量致鱗嵩 、、’菌活I1生’該致齲齒細菌包括變形鏈球菌(s似)。 述申請專利範圍之任一項之方法,其中該方法係於對牙 齒有可測量或顯著脫礦化或傷害之前檢測牙菌斑生態之潛在 有害變化。 9.—種增進口腔健康之方法 ,例如,以 a·減少或抑制形成齲齒; b.減少或抑制牙齒之脫礦化作用及促進礦化作用 19 200948966 C.治療、減少或抑制早期牙釉質病變; d. 減少牙齒之過敏反應; e. 減少或抑制牙齦炎; f. 促進口中潰瘍或傷口之癒合; 5 g.減少產酸細菌量; h. 增加分解精胺酸細菌之相對量; i. 抑制口腔中微生物生物膜之形成; j. 於糖刺激後提升及/或維持牙菌斑pH於至少pH 5.5 之程度; 10 k.減少牙菌斑堆積; l. 治療、緩和或減少口乾; m. 美白牙齒; η.增進全身健康,包括心血管健康; 〇.保護牙齒對抗致齲齒細菌或對其免疫; 15 Ρ.清潔牙齒及口腔及/或 q.減少牙齒腐I虫; 該方法包括使用根據前述申請專利範圍之任一項之方法測 量口腔之生物菌叢,若指示 出現致鶴齒細菌量上升及/或乳酸量上升、及/或 20 9200948966 出現分解精胺酸細菌 則投與含有效量驗性胺基 量下降及/或牙菌斑氨產生量下降 酸或其鹽之口腔保健產品。 10.如申請專利範圍第9 或其鹽。 項之方法’其中該鹼性胺基酸為精胺酸 ❹ 攄一/If或鹽型之鹼性胺基酸製造藥劑之用途,其針 谁别V π專利範圍之任一項之方法所測量,其用於增 心者口腔健康’該患者之口腔生物g叢含有賴齒細菌量 上升及/或礼酸篁上升、及/或低分解精胺酸細菌量及/或 菌斑氨產生量。 10 12.-,增進口腔美觀之方法,該方法包括使用根據中請專利範 圍第1至10項之任一項之方法測量口腔生物菌叢,若指示出 現致齲齒細菌量上升及/或乳酸量上升、及/或出現分解精胺 酸細菌量下降及/或牙菌斑氨產生量下降,則投與含有呈游離 或鹽型鹼性胺基酸之口腔保健產品。4. The method of measuring the amount of lactic acid produced is evaluated as in the second or third aspect of the patent application. VIII. The bacterial activity of the genus 5. The range of benefits, including the use of quantitative = day-to-day, quantitative RT_PCR, and / or $ light antibody probes to quantify at least one cariogenic bacteria and / or at least A quantity that decomposes arginine bacteria. The above-mentioned application is a method of the term "the term", wherein the decomposition of arginine, and the scorpion includes Streptococcus sanguis S. 7. The method according to any one of the preceding claims, wherein the squamous sputum, the bacterium, the bacterium, the bacterium, the bacterium of the genus Streptococcus mutans (s-like). A method of any of the claims, wherein the method is for detecting potentially harmful changes in the plaque ecology prior to measurable or significant demineralization or injury to the teeth. 9. A method for improving oral health, for example, a. reducing or inhibiting the formation of dental caries; b. reducing or inhibiting demineralization of teeth and promoting mineralization 19 200948966 C. treating, reducing or inhibiting early enamel lesions d. Reduce allergic reactions to teeth; e. Reduce or inhibit gingivitis; f. Promote healing of ulcers or wounds in the mouth; 5 g. Reduce the amount of acid-producing bacteria; h. Increase the relative amount of bacteria that break down arginine; To inhibit the formation of microbial biofilms in the oral cavity; j. to increase and/or maintain the plaque pH to at least pH 5.5 after sugar stimulation; 10 k. reduce plaque accumulation; l. treat, alleviate or reduce dry mouth; m. whitening teeth; η. improve overall health, including cardiovascular health; 〇 protect teeth against caries bacteria or immunize them; 15 清洁 clean teeth and mouth and / or q. reduce tooth decay I insects; The use of the method according to any one of the preceding claims to measure the bacterial flora of the oral cavity, if the indication indicates an increase in the amount of bacteria and/or an increase in the amount of lactic acid, and/or the decomposition of 20 9200948966 Amine acid bacteria containing an effective amount of the administration of the test group decreased and / or decrease the amount of plaque acid produced ammonia or salt thereof in oral care products. 10. If you apply for patent scope 9 or its salt. The method of the invention wherein the basic amino acid is a succinic acid hydrazine/I or a salt-based basic amino acid, and the method of the method of measuring any one of the V π patent ranges It is used for oral health of the patient. The oral biog plexus of the patient contains an increase in the amount of bacteria and/or an increase in sputum sputum, and/or a low decomposition of arginine bacteria and/or plaque ammonia production. 10 12.- A method for improving the aesthetics of the mouth, the method comprising measuring the oral flora with the method according to any one of the items 1 to 10 of the patent application, if the amount of bacteria causing caries is increased and/or the amount of lactic acid is indicated If the amount of bacteria that degrades arginine is decreased and/or the amount of plaque ammonia is decreased, an oral health care product containing a free or salt-type basic amino acid is administered. 21twenty one
TW98103785A 2008-02-08 2009-02-06 Oral care methods and systems TWI424063B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US2742008P 2008-02-08 2008-02-08
US2743108P 2008-02-08 2008-02-08
US2743508P 2008-02-08 2008-02-08
US2743208P 2008-02-08 2008-02-08
US2743708P 2008-02-09 2008-02-09
US2744208P 2008-02-09 2008-02-09

Publications (2)

Publication Number Publication Date
TW200948966A true TW200948966A (en) 2009-12-01
TWI424063B TWI424063B (en) 2014-01-21

Family

ID=42062127

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98103785A TWI424063B (en) 2008-02-08 2009-02-06 Oral care methods and systems

Country Status (2)

Country Link
AR (1) AR070354A1 (en)
TW (1) TWI424063B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0323211D0 (en) * 2003-10-03 2003-11-05 Toshiba Res Europ Ltd Signal decoding methods and apparatus

Also Published As

Publication number Publication date
AR070354A1 (en) 2010-03-31
TWI424063B (en) 2014-01-21

Similar Documents

Publication Publication Date Title
RU2476890C2 (en) Oral care methods and systems
Horz et al. Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real‐time quantitative polymerase chain reaction
Crielaard et al. Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health
Mantzourani et al. Association between Bifidobacteriaceae and the clinical severity of root caries lesions
Page Milestones in periodontal research and the remaining critical issues
Morozumi et al. Effects of irrigation with an antiseptic and oral administration of azithromycin on bacteremia caused by scaling and root planing
Neves et al. Comparison between clinical aspects and salivary microbial profile of children with and without early childhood caries: a preliminary study
Dame-Teixeira et al. Presence of Archaea in dental caries biofilms
Balaei-Gajan et al. Detection of Enterococcus faecalis in subgingival biofilm of patients with chronic refractory periodontitis
Rams et al. Introduction to clinical microbiology for the general dentist
Reyes et al. Bacterial diversity in the saliva and plaque of caries-free and caries-active Filipino adults
Sari et al. Antibacterial and antifungal effectiveness of virgin coconut oil (VCO) mousse against Streptococcus mutans and candida albicans biofilms
Abram et al. A co-association of Streptococcus mutans and Veillonella parvula/dispar in root caries patients and in vitro biofilms
Doğan et al. Occurrence and serotype distribution of Aggregatibacter actinomycetemcomitans in subjects without periodontitis in Turkey
Abd Al-Zahra et al. Isolation and identification of Streptococcus mutans from dental caries patients at Thi-Qar province/Iraq
TW200948966A (en) Oral care methods and systems
Sereti et al. Microbiological testing of clinical samples before and after periodontal treatment. A comparative methodological study between real‐time PCR and real‐time‐PCR associated to propidium monoazide
Culp et al. In vivo colonization with candidate oral probiotics attenuates Streptococcus mutans colonization and virulence
Ealla et al. Comparative analysis of colony counts of different species of oral streptococci in saliva of dentulous, edentulous and in those wearing partial and complete dentures
Vishwanathan et al. Effect of full-mouth rehabilitation on Streptococcus mutans and Streptococcus sobrinus levels in children with severe early childhood caries
Stojanovska et al. Identification of periopathogenes from dental plaque in periodontal patients with PCR technique and their association with composite interleukin-1 genotype
Sreeja Assessment of Genotypic Diversity of Streptococcus mutans in Caries Active Mentally Retarded and Normal Children-An in vivo Study
Elbattawy et al. The effect of irrigating solutions on postoperative pain and intensity of bacteremia following single visit root canal treatment
정우선 Quantitative analysis of changes in salivary mutans streptococci levels after orthodontic treatment
Nikolić-Jakoba et al. Polymerase chain reaction in the identification of periodontopathogens: A reliable and satisfactory method?

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees